Neurotrophin Family Members as Neuroprotectants in Retinal Degenerations Edoardo AbedGiovanni CorboBenedetto Falsini Review Article 19 November 2014 Pages: 1 - 13
Peptide-Based Vaccination and Induction of CD8+ T-Cell Responses Against Tumor Antigens in Breast Cancer Michiko HaraoElizabeth A. MittendorfLaszlo G. Radvanyi Review Article 19 December 2014 Pages: 15 - 30
Enzymes Approved for Human Therapy: Indications, Mechanisms and Adverse Effects Brian A. Baldo Review Article 04 February 2015 Pages: 31 - 55
Vedolizumab: A Review of Its Use in Adult Patients with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease K. P. Garnock-Jones Adis Drug Evaluation 11 December 2014 Pages: 57 - 67
Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate Quality-Adjusted Life-Years Luciana ScalonePaolo A. Cortesi Letter to the Editor 30 January 2015 Pages: 69 - 69
Reply to Scalone and Cortesi: “Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs” Federico SpandonaroFabio AyalaPiergiacomo Calzavara Pinton Letter to the Editor 03 February 2015 Pages: 71 - 72
Erratum to: Vedolizumab: A Review of Its Use in Adult Patients with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease K. P. Garnock-Jones Erratum 15 January 2015 Pages: 73 - 73
